Complex incentives drive macular degeneration prescription decisions

Researchers suspected that doctors treating Medicare patients would have a financial incentive to prescribe a more costly drug. Instead the prescription practices for two macular degeneration drugs aren't that straightforward.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1zBOqwt